FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

PMA Safety/Effectiveness Summaries Available

Federal Register notice: FDA posts a list PMAs, and associated safety and effectiveness summaries, that have been approved from 10/1/2018 through 12/3...

Biologics

AstraZeneca Scrutinized on Covid Vaccine Data

A clinical trial data and safety monitoring board questions AstraZenecas data it presented in a press release about its Covid-19 vaccine.

Human Drugs

Oramed Starts Second Phase 3 Insulin Capsule Trial

Oramed says it is recruiting patients for a second Phase 3 study of its investigational oral insulin capsule to treat Type 2 diabetes in patients with...

Human Drugs

Reject New Mexico Drug Import Proposal: Stakeholders

Three major drug advocacy groups petition FDA not to authorize a drug importation program proposed by New Mexico.

Federal Register

Comments Reopened on Drug Supply Chain Pilot

Federal Register notice: FDA reopens the comment period for a 10/28 notice entitled The Drug Supply Chain Security Act Pilot Project Program and Enhan...

Human Drugs

Petition Asks FDA Jakafi Safety Labeling Actions

A petition asks FDA to open a docket and solicit comments on possible Boxed Warnings for Jakafi and other JAK inhibitors.

Human Drugs

Mercks Keytruda Approved for Esophageal Carcinoma

FDA approves Mercks Keytruda (pembrolizumab) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or loca...

Medical Devices

Summary Judgment in Class 3 Device Case

Attorney Michelle Yeary analyzes a medical device case that was dismissed by an Alabama federal court on both medical causation and preemption grounds...

Human Drugs

FDA Adds 1 Bulk Drug for Compounding, Rules Out 4 Drugs

FDA proposes to add one active ingredient to the bulk drug substance list for drug compounding and proposes not to add four other substances.

Human Drugs

Fresenius Kabi to Pay $50 Million in FDA Records Case

The Justice Department says Fresenius Kabi Oncology was ordered to pay $50 million in fines and forfeitures after pleading guilty to failing to provid...